These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17273608)

  • 1. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
    J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
    Jonkers RE; Bantje TA; Aalbers R
    Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
    Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
    Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
    Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
    Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S; Hancox RJ
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH; Otis J; Kline PA; Gontovnick LS; Hargreave FE; O'Byrne PM
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
    Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
    Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
    Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children.
    Amirav I; Yacobov R; Luder AS
    J Aerosol Med; 2007; 20(1):1-6. PubMed ID: 17388747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers.
    Haidl P; Schmidt F; Wiese C; Koehler D
    J Aerosol Med; 2006; 19(3):364-71. PubMed ID: 17034311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
    Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G
    Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.